280 related articles for article (PubMed ID: 27692510)
1. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
Du L; Wang X; Cui G; Xu B
Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
Cui G; Jin J; Chen H; Cao R; Chen X; Xu B
Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270
[TBL] [Abstract][Full Text] [Related]
4. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L
Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446
[TBL] [Abstract][Full Text] [Related]
6. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors.
Wang S; Guan L; Zang J; Xing K; Zhang J; Liu D; Zhao L
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934730
[TBL] [Abstract][Full Text] [Related]
8. Dual Roles of Pin1 in Cancer Development and Progression.
Han HJ; Choi BY; Surh YJ
Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
[TBL] [Abstract][Full Text] [Related]
9. Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1).
Liu L; Zhu R; Li J; Pei Y; Wang S; Xu P; Wang M; Wen Y; Zhang H; Du D; Ding H; Jiang H; Chen K; Zhou B; Yu L; Luo C
J Med Chem; 2022 Feb; 65(3):2174-2190. PubMed ID: 35089030
[TBL] [Abstract][Full Text] [Related]
10. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors.
Li X; Li L; Zhou Q; Zhang N; Zhang S; Zhao R; Liu D; Jing Y; Zhao L
Bioorg Med Chem Lett; 2014 Dec; 24(24):5612-5615. PubMed ID: 25466185
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocket.
Guo C; Hou X; Dong L; Marakovits J; Greasley S; Dagostino E; Ferre R; Johnson MC; Humphries PS; Li H; Paderes GD; Piraino J; Kraynov E; Murray BW
Bioorg Med Chem Lett; 2014 Sep; 24(17):4187-91. PubMed ID: 25091930
[TBL] [Abstract][Full Text] [Related]
13. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
14. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
[TBL] [Abstract][Full Text] [Related]
15. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
16. Substrate-based design of reversible Pin1 inhibitors.
Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
[TBL] [Abstract][Full Text] [Related]
17. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel selenium derivatives as Pin1 inhibitors by high-throughput screening.
Subedi A; Shimizu T; Ryo A; Sanada E; Watanabe N; Osada H
Biochem Biophys Res Commun; 2016 Jun; 474(3):528-533. PubMed ID: 27120460
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
[TBL] [Abstract][Full Text] [Related]
20. Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors.
da Costa KS; Galúcio JM; de Jesus DA; Gomes GC; Lima E Lima AH; Taube PS; Dos Santos AM; Lameira J
Curr Comput Aided Drug Des; 2020; 16(5):605-617. PubMed ID: 31654518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
